Tsubota Laboratory Incorporated (TYO:4890)
266.00
-7.00 (-2.56%)
Feb 16, 2026, 3:30 PM JST
Tsubota Laboratory Company Description
Tsubota Laboratory Incorporated engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders.
The company was incorporated in 2012 and is based in Tokyo, Japan.
Tsubota Laboratory Incorporated
| Country | Japan |
| Founded | 2012 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Kazuo Tsubota |
Contact Details
Address: CRIK Shinanomachi E7, Bldg. 2 Tokyo, 160-8582 Japan | |
| Phone | 81 3 6384 2866 |
| Website | tsubota-lab.com |
Stock Details
| Ticker Symbol | 4890 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3535700003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kazuo Tsubota | Chief Executive Officer |